Skip to main content

Table 1 Patients’ baseline characteristics, coexisting medical conditions, intraoperative characteristics, and surgical procedures by acute kidney injury (N=6296)

From: Analysis of intraoperative modifiable factors to prevent acute kidney injury after elective noncardiac surgery: intraoperative hypotension and crystalloid administration related to acute kidney injury

 

Non-AKI (n=5865)

AKI (n=431)

p value

Baseline patient characteristics

 Sex (female), n (%)

 

2143 (36.54)

107 (24.83)

< 0.0001

 Age, years

≥50, <65

1515 (25.83)

90 (20.88)

0.0840

≥65

4350 (74.17)

341 (79.12)

0.4113

 BMI, kg m−2

<25

1621 (27.64)

127 (29.47)

0.5769

≥25

4244 (72.36)

304 (70.53)

0.7709

 ASAPS, n (%)

2

4955 (84.50)

326 (75.60)

0.1555

3

868 (14.80)

98 (22.70)

0.0003

4

42 (0.72)

7 (1.62)

0.0778

 Cardiac medication histories, n (%)

ACE inhibitors

393 (6.70)

51 (11.83)

<0.0001

ARBs

1651 (28.15)

148 (34.34)

0.0072

Beta blockers

878 (14.97)

115 (26.68)

<0.0001

CCBs

2177 (37.10)

211 (48.90)

<0.0001

Diuretics

481 (8.20)

73 (16.94)

<0.0001

 Baseline systolic BP, mmHg

 

123 ± 17.8

125 ±19.6

0.2300a

 Baseline eGFR, ml min−1 1.73m−2

15≤ <45

623 (10.62)

116 (26.91)

<0.0001

≥45

5242 (89.38)

315 (73.09)

0.0094

Coexisting medical conditions

 Congestive heart failure, n (%)

 

330 (5.63)

35 (8.12)

0.0422

 Hypertension, n (%)

 

3275 (55.84)

298 (69.14)

<0.0001

 Coronary artery disease, n (%)

 

607 (10.35)

62 (14.39)

0.0110

 Valvular heart disease, n (%)

 

401 (6.84)

42 (9.74)

0.0292

 Diabetes mellitus, n (%)

 

1392 (23.73)

127 (29.47)

0.0086

 Dyslipidemia, n (%)

 

1550 (26.43)

120 (27.84)

0.5583

 Cerebrovascular disease, n (%)

 

472 (8.05)

52 (12.06)

0.0047

 Spinal cord injury, n (%)

 

6 (0.10)

1 (0.23)

0.9751

 COPD, n (%)

 

945 (16.11)

57 (13.23)

0.1302

 Interstitial pneumonia, n (%)

 

397 (6.77)

28 (6.50)

0.9060

 Mixed obstructive and restrictive lung disease, n (%)

 

90 (1.53)

11 (2.55)

0.1543

 Respiratory failure, n (%)

 

354 (6.04)

16 (3.71)

0.0610

 Cirrhosis, n (%)

 

53 (0.90)

11 (2.55)

0.0023

 Coagulopathy, n (%)

 

159 (2.71)

17 (3.94)

0.1777

 Hyperthyroidism, n (%)

 

114 (1.94)

10 (2.32)

0.7164

 Neuromuscular disease, n (%)

 

32 (0.55)

1 (0.23)

0.5998

 Parkinson’s disease, n (%)

 

18 (0.31)

3 (0.70)

0.3578

 Depression, n (%)

 

55 (0.94)

11 (2.55)

0.0034

 Schizophrenia, n (%)

 

19 (0.32)

1 (0.23)

1.0000

 Dementia, n (%)

 

62 (1.06)

3 (0.70)

0.6392

 Ileus, n (%)

 

15 (0.26)

3 (0.70)

0.2360

Intraoperative factors

 Anesthesia time, min

>60, ≤278

1480 (25.23)

46 (10.67)

<0.0001

>278, ≤372

1499 (25.56)

53 (12.30)

<0.0001

>372, ≤501

1486 (25.34)

125 (29.00)

0.2205

501<

1400 (23.87)

207 (48.03)

<0.0001

 Hemorrhage, ml

0

1457 (24.84)

44 (10.21)

<0.0001

>0, ≤100

1283 (21.88)

37 (8.58)

<0.0001

>100, ≤330

1739 (29.65)

107 (24.83)

0.1229

>330

1386 (23.63)

243 (56.83)

<0.0001

 Crystalloid, ml kg−1 h−1

≥7, <24

3950 (67.34)

263 (61.02)

0.2380

≥24

168 (2.86)

11 (2.55)

0.8280

≥0, <7

1747 (29.78)

157 (36.42)

0.0420

 0.9% saline, n (%)

 

2383 (40.63)

223 (51.74)

<0.0001

 Synthetic colloid, n (%)

 

2094 (35.70)

235 (54.52)

<0.0001

 Transfusion, n (%)

RBC

486 (8.29)

115 (26.68)

<0.0001

FFP

140 (2.39)

43 (9.98)

<0.0001

 Urine, ml kg−1 h−1

≥0.5

4475 (76.30)

314 (72.85)

0.1188

≥0, <0.5

1390 (23.70)

117 (27.15)

0.2314

 Combined epidural anesthesia, n (%)

 

2371 (40.43)

196 (45.48)

0.0446

 Use of arterial catheter, n (%)

 

4280 (73.10)

361 (83.76)

<0.0001

Surgical procedures

 Major abdominal

1263 (21.53)

190 (44.08)

<0.0001

 Laparoscopic major abdominal

833 (14.20)

35 (8.12)

0.0021

 Gynecological

160 (2.73)

6 (1.39)

0.1389

 Thoracic

1566 (26.70)

42 (9.74)

<0.0001

 Major vascular

617 (10.52)

94 (21.81)

<0.0001

 Peripheral vascular

205 (3.50)

12 (2.78)

0.5354

 Neurosurgery

381 (6.50)

9 (2.09)

0.0007

 Spinal surgery

189 (3.22)

4 (0.93)

0.0137

 Orthopedic surgery

192 (3.27)

8 (1.86)

0.1512

 Head and neck

226 (3.85)

13 (3.02)

0.4733

 Other high-risk surgeries

59 (1.01)

15 (3.48)

<0.0001

 Other low-risk surgeries

174 (2.97)

3 (0.70)

0.0108

  1. Data are presented as mean ± SD, n (%). All p values are derived from Chi-squared tests
  2. ap value derived from t-test
  3. BMI body mass index, ASAPS American Society of Anesthesiologists Physical Status, ACE angiotensin-converting enzyme, ARB angiotensin receptor blocker, CCB calcium channel blocker, BP blood pressure, eGFR estimated glomerular filtration rate, COPD chronic obstructive pulmonary disease, RBC red blood cells, FFP fresh frozen plasma